BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 27645887)

  • 1. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
    Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
    Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Suppression of Onchocerciasis Transmission in Bioko Island, Equatorial Guinea.
    Moya L; Herrador Z; Ta-Tang TH; Rubio JM; Perteguer MJ; Hernandez-González A; García B; Nguema R; Nguema J; Ncogo P; Garate T; Benito A; Sima A; Aparicio P
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004829. PubMed ID: 27448085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.
    Herrador Z; Garcia B; Ncogo P; Perteguer MJ; Rubio JM; Rivas E; Cimas M; Ordoñez G; de Pablos S; Hernández-González A; Nguema R; Moya L; Romay-Barja M; Garate T; Barbre K; Benito A
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006471. PubMed ID: 29723238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
    Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
    Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
    Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
    Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
    Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
    Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
    Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population biology of human onchocerciasis.
    Basáñez MG; Boussinesq M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.
    Gómez-Priego A; Mendoza R; de-la-Rosa JL
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):40-3. PubMed ID: 15642982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, geographical distribution and clinical manifestations of onchocerciasis on the Island of Bioko (Equatorial Guinea).
    Mas J; Yumbe A; Solé N; Capote R; Cremades T
    Trop Med Parasitol; 1995 Mar; 46(1):13-8. PubMed ID: 7631122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
    Golden A; Faulx D; Kalnoky M; Stevens E; Yokobe L; Peck R; Karabou P; Banla M; Rao R; Adade K; Gantin RG; Komlan K; Soboslay PT; de Los Santos T; Domingo GJ
    Parasit Vectors; 2016 Jun; 9(1):338. PubMed ID: 27296630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
    Hendy A; Krüger A; Pfarr K; De Witte J; Kibweja A; Mwingira U; Dujardin JC; Post R; Colebunders R; O'Neill S; Kalinga A
    Acta Trop; 2018 May; 181():50-59. PubMed ID: 29410302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.
    Bakajika D; Senyonjo L; Enyong P; Oye J; Biholong B; Elhassan E; Boakye D; Dixon R; Schmidt E
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006904. PubMed ID: 30427830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23.
    Vlaminck J; Lagatie O; Verheyen A; Dana D; Van Dorst B; Mekonnen Z; Levecke B; Stuyver LJ
    Parasit Vectors; 2019 Jan; 12(1):63. PubMed ID: 30691520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
    Lont YL; Coffeng LE; de Vlas SJ; Golden A; de Los Santos T; Domingo GJ; Stolk WA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005314. PubMed ID: 28114304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted.
    Katabarwa M; Lakwo T; Habomugisha P; Agunyo S; Byamukama E; Oguttu D; Ndyomugyenyi R; Tukesiga E; Ochieng GO; Abwaimo F; Onapa A; Lwamafa DW; Walsh F; Unnasch TR; Richards FO
    Am J Trop Med Hyg; 2014 Jun; 90(6):1159-66. PubMed ID: 24686740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.